Monday May 29th 2017

[Comment] New evidence for teriflunomide in multiple sclerosis

Multiple sclerosis is an inflammatory demyelinating disorder of the CNS and one of the most common causes of sustained neurological disability in young adults. For 20 years, since immunomodulation was introduced for the treatment of relapse activity, interferon beta and glatiramer acetate have been the mainstay of therapy. These treatments are only partly effective, and their effects on the reduction of disability progression are debated. They are administered subcutaneously or intramuscularly, which might affect acceptance and patient adherence. (Source: Lancet Neurology)

Link – 

[Comment] New evidence for teriflunomide in multiple sclerosis

Leave a Comment

More from category

New sleep system helps profoundly disabled 5-year-old boy with complex care needs to get full night’s sleep
New sleep system helps profoundly disabled 5-year-old boy with complex care needs to get full night’s sleep

A 5-year-old boy, who is profoundly disabled and has complex needs, has been given his first full night’s sleep [Read More]

Revisions Underway to McDonald Criteria on MS Diagnosis Revisions Underway to McDonald Criteria on MS Diagnosis
Revisions Underway to McDonald Criteria on MS Diagnosis Revisions Underway to McDonald Criteria on MS Diagnosis

An expert panel is tackling the first revision to the multiple sclerosis diagnostic criteria in 7 years. Among proposed [Read More]

Connecticut State Budget Call to Action
Connecticut State Budget Call to Action

/About-the-Society/News/Connecticut-State-Budget-Call-to-Action [Read More]

A Surge of New Drug Data in Multiple Sclerosis A Surge of New Drug Data in Multiple Sclerosis
A Surge of New Drug Data in Multiple Sclerosis A Surge of New Drug Data in Multiple Sclerosis

Medscape sits down with two neurologists to discuss advances in multiple sclerosis as presented at this year's American [Read More]

Progress on Bills to Address Step Therapy
Progress on Bills to Address Step Therapy

/About-the-Society/News/Progress-on-Bills-to-Address-Step-Therapy [Read More]